We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALLPhi)

This study has been terminated.
(The study was terminated due to excessive toxicity and low compliance to the protocol scheme.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00905398
First Posted: May 20, 2009
Last Update Posted: July 9, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Rony Schaffel, Universidade Federal do Rio de Janeiro
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2015
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)